* 金域醫學上半年淨利大增90.55%,2024年第三方檢測市場有望突破800億元

8月16日盤後,$金域醫學(603882)$ 發佈公告:上半年營業收入54.55億元,同比增長57.01%;淨利潤10.59億元,同比增長90.55%。

 

公司表示,報告期內積極參與國家新冠疫情防控工作,截至2021年6月30日累計核酸檢測量超過9900萬份。三級醫院收入繼續保持高速增長,收入佔比進一步提高至34.48%,區域獨立法人業務戰略穩步推進。

 

有市場觀點認爲,公司依託自身強大的病毒檢測能力,積極參與全國抗擊新冠肺炎疫情戰鬥。拋開疫情因素,目前我國第三方醫療檢驗機構滲透率有非常大的提升空間,短期內市場規模預計將保持高速增長趨勢。資料顯示,2019年第三方醫學檢驗市場規模達到252.7億元,年複合增長率爲29.26%,預計至2024年市場規模有望突破800億元。

 

2021年金域醫學保持高位震盪走勢,截至8月16日,年內漲幅6.7%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment1

  • Top
  • Latest
  • TorisQ
    ·2021-08-17
    mark
    Reply
    Report